Sánchez Magraner L, Miles J, Baker C, Applebee C, Lee D, Elsheikh S, et al. High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment. Cancer Res. 2020;80:4244-4257 pubmed publisher

de Souza T, da Silva A, Pereira L, Figueiredo F, Mendes Júnior A, Menezes R, et al. Pro-Cellular Exhaustion Markers are Associated with Splenic Microarchitecture Disorganization and Parasite Load in Dogs with Visceral Leishmaniasis. Sci Rep. 2019;9:12962 pubmed publisher

Kümpers C, Jokic M, Haase O, Offermann A, Vogel W, Grätz V, et al. Immune Cell Infiltration of the Primary Tumor, Not PD-L1 Status, Is Associated With Improved Response to Checkpoint Inhibition in Metastatic Melanoma. Front Med (Lausanne). 2019;6:27 pubmed publisher

Gulati N, Suárez Fariñas M, Correa Da Rosa J, Krueger J. Psoriasis is characterized by deficient negative immune regulation compared to transient delayed-type hypersensitivity reactions. F1000Res. 2015;4:149 pubmed publisher

Mittal A, Chaturvedi N, Rohlfsen R, Gupta P, Joshi A, Hegde G, et al. Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia. PLoS ONE. 2013;8:e70352 pubmed publisher

Suárez Fariñas M, Li K, Fuentes Duculan J, Hayden K, Brodmerkel C, Krueger J. Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol. 2012;132:2552-64 pubmed publisher

Kozik P, Francis R, Seaman M, Robinson M. A screen for endocytic motifs. Traffic. 2010;11:843-55 pubmed publisher